Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXR3K6
|
||||
Drug Name |
1-[4-(8-Chloro-10-methyl-10,11-dihydro-5H-4,10-diaza-dibenzo[a,d]cyclohepten-5-yl)-piperazin-1-yl]-2-(1-oxy-pyridin-4-yl)-ethanone
|
||||
Synonyms |
CHEMBL84036
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C25H26ClN5O2
|
||||
Canonical SMILES |
CN1Cc2cccnc2C(N3CCN(CC3)C(=O)Cc4cc[n+]([O-])cc4)c5ccc(Cl)cc15
|
||||
InChI |
InChI=1S/C25H26ClN5O2/c1-28-17-19-3-2-8-27-24(19)25(21-5-4-20(26)16-22(21)28)30-13-11-29(12-14-30)23(32)15-18-6-9-31(33)10-7-18/h2-10,16,25H,11-15,17H2,1H3
|
||||
InChIKey |
LQKAVYVOISWFQF-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.